Navigation Links
Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents
Date:5/15/2008

Randomized TRIAS HR Pilot Study Compares Genous, Boston Scientific's

Taxus(R) Other Presentations Focus on Real-World Use of Genous, Stent's Performance

in Patients with AMI, Those Who Could Not Tolerate Dual-Antiplatelet

Therapy

BARCELONA, Spain, May 15 /PRNewswire/ -- OrbusNeich today announced that multiple clinical data presentations in a symposium at EuroPCR 2008 support the use of the company's Genous Bio-engineered R stent, the world's first pro-healing stent, as a safe alternative to drug-eluting stents.

12-Month TRIAS HR Pilot Study Data

Presented by Robbert de Winter, M.D., Ph.D., of the Academic Medical Center in Amsterdam, data from the TRIAS HR (high risk) Pilot study show similar target vessel failure (TVF) rates at 12-month follow-up for OrbusNeich's Genous Bio-engineered R stent and Boston Scientific's Taxus stent in high risk of restenosis patients.

In the patients treated with Taxus, there were four out-of-hospital thrombotic events, while there were no reported events in the Genous group. TRIAS HR Pilot is a randomized, 193-patient, single-center, prospective, single-blind study involving patients with a high risk of restenosis. High risk of restenosis is defined as patients who have diabetes mellitus and/or small vessels (less than 2.8 mm) and/or long lesions (greater than 23 mm) and/or chronic total occlusions.

"Interventional cardiologists need better stent technologies," said de Winter, principal investigator of the TRIAS HR Pilot study. "A pro-healing approach with the Genous stent is a viable one. We look forward to obtaining further data on the stent's performance in our large, multi-center TRIAS trials that compare Genous to both drug-eluting and bare metal stents."

e-HEALING Interim Patient Subset Data

In addition, de Winter presented interim follow-up data from patient subsets of e-HEALING, a monitored, m
'/>"/>

SOURCE OrbusNeich
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
3. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
4. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
5. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
6. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
7. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
8. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
9. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
10. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
11. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)... , CHICAGO, Nov. 29 Research...MRI) to study brain activation have found that men...ative stimuli, according to a study presented toda...y of North America (RSNA). ,, "Men may direct m...uli and tend to process them in terms of implicati...
(Date:11/28/2009)... , CHICAGO, Nov. 28 Sieme...neration of its Tim ® (Total imaging matrix)...ng throughput) engine. Both technologies are intro...(T) and the new MAGNETOM Skyra* 3T scanners at the...e Radiological Society of North America (RSNA) fro...
(Date:11/27/2009)... , Another option to prevent illnesses..., SILVER SPRING, Md., Nov. 27 /PRNewswire-USNewswi... approved Agriflu for people ages 18 years and old...btypes A and B. ,, (Logo: http://www.newscom..., manufactured by Novartis Vaccines and Diagnostic...
Breaking Medicine Technology:New Study Finds Men and Women May Respond Differently to Danger 2New Study Finds Men and Women May Respond Differently to Danger 3Siemens Introduces Its New Power Couple at RSNA 2009 2Siemens Introduces Its New Power Couple at RSNA 2009 3Siemens Introduces Its New Power Couple at RSNA 2009 4Siemens Introduces Its New Power Couple at RSNA 2009 5Siemens Introduces Its New Power Couple at RSNA 2009 6Siemens Introduces Its New Power Couple at RSNA 2009 7FDA Approves Agriflu Seasonal Influenza Vaccine 2Luminous Medical Inc Secures Exclusive Rights to Glucose Sensor for Its Automated Glucose Monitor 5451 1Luminous Medical Inc Secures Exclusive Rights to Glucose Sensor for Its Automated Glucose Monitor 5451 2Holston Valley Ranks No 1 in Tennessee for Cardiology 59411 1Holston Valley Ranks No 1 in Tennessee for Cardiology 59411 2AHIP Statement on Passage of Senate Finance Committee Legislation 59409 1AHIP Statement on Passage of Senate Finance Committee Legislation 59409 2
...affirms Primacy and Safety of ,First Generation, A...Incorporated (Nasdaq: GNTA ) announced the presen...mersen sodium) Injection, its lead anticancer,comp...a brief intravenous,(IV) infusion. The new data we...linical Research, South Texas Accelerated Research...
...ow Improvement in Hemodynamics and Delay Disease P...uticals US, Inc.,today announced positive results ...sentan) may be safe and effective as a combination...ypertension (PAH). Data from both,studies suggest ...enafil,is well-tolerated and improves hemodynamics...
Other Medicine Technology:Genasense(R) Can be Administered by Brief High-Dose IV Infusion 2Genasense(R) Can be Administered by Brief High-Dose IV Infusion 3Genasense(R) Can be Administered by Brief High-Dose IV Infusion 4Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension 2Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension 3
(Date:11/29/2009)...or something leads to more self-defensive finger p... (HealthDay News) -- The blame game is a contagiou...s innocent. , Researchers found that when peopl...en if it,s an unfair accusation, they,re much more...hen we see others protecting their egos, we become...
(Date:11/29/2009)...of treatment equals a $41,000 pay raise, researche...News) -- Psychological therapy may be much more ef...e or winning a lottery prize, suggests an English ... of people who provided information about their me...piness from a $1,329 course of therapy was so sign...
(Date:11/29/2009)...disorder boosts urine production, experts say , ...ple who wake up during the night to urinate should...p apnea, a breathing-related sleep disorder, could...ttime urination, or nocturia, is comparable to lou... a disorder in which soft tissue in the throat blo...
(Date:11/29/2009)...;The YogaForce A-Line Athletic Mat is great. It,s....D., author and physician best known for establish...cine. Go to www.yogaforce.com and order the new.... , San Francisco, CA (PR...idays, the YogaForce newly patented, revolutionary...
(Date:11/29/2009)...tional healthcare,s uncertain future and rising co...e care. Affordable Acupuncture Scottsdale answers ...ber 29, 2009 -- Affordable Acupuncture, LLC opened... been met with enthusiasm and gratitude. Its incre...ed to two things, need and cost. "As far as ...
Breaking Medicine News(10 mins):Health News:When Accusations Start to Fly, They Multiply 2Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2Health News:Sleep Apnea May Cause Nighttime Urination 2Health News:Sleep Apnea May Cause Nighttime Urination 3Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 3Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2
...on Remicade (infliximab) showed rapid, significant...laque psoriasis. The stud mainly used placebo-// c...The continuous eight week maintenance therapy resu...ients treated with Remicade 3 mg/kg and 75 % of pa...
...rn consumers on how to spot the misleading promoti...d nutritional HGH products.// Various spray ...uct manufacturers, distributors, or resellers are ...), representing 17,500 physicians in 86 nations wo...
... polyunsaturated fatty acids it has been revealed ...ealth benefits. // They influence mood, persona... study presented by University of Pittsburgh Schoo...olunteers. The researchers found that participants...
...sionals Follow-up Study has gathered data on men's...d questions on sexuality in 2000 to what is a semi...vard Men’s Health Watch says that there are some u... followed by chronic illnesses such as diabetes, h...
...the protective clothing to astronauts going to spa...forming as the basis to design// protective clothi... work in extreme heat and dangerous circumstances....kin to space suits used by astronauts. According t...
... kidnapped a couple’s 26 day old baby from a Strog...g to authorities//. The woman is now in police cus...ated kidnapping had appeared before Judge Raymond ...y fled the scene with the baby. The police ...
Other Medicine News:Health News:Beware Of Bogus Claims by HGH Spray Internet Marketers 2Health News:Beware Of Bogus Claims by HGH Spray Internet Marketers 3
IDS Rapid SS/u
Versatrek 240
ELP 40
96 PW Microplate Washer
Medicine Products: